Insulin discovered 1921 sold nearly cost century ago — founders sold patent cheap for humanity. Today some Americans pay hundreds monthly same vial, ration doses die, cross border Canada Mexico buy, GoFundMe insulin recurring theme. Not shortage drug — pricing architecture problem embedded healthcare system.
Who needs insulin
Type 1 autoimmune — body produces none; lifelong dependent; death days without.
Type 2 some — progression insulin required; growing population.
Gestational temporary — pregnancy subset.
Approx 8+ million US insulin dependent — not optional lifestyle drug.
Price mechanics obscured
List price — manufacturer sticker absurd high; not what plans pay entirely.
Rebates PBMs — pharmacy benefit managers middlemen; formulary placement negotiated; spread pricing opaque; incentives keep list high rebate larger fiction.
Patent evergreening — incremental delivery devices extend monopoly; biosimilar slower US than Europe.
Uninsured pay list — catastrophe; underinsured high deductible hit hard months.
Medicare cap — Inflation Reduction Act $35/month cap Part D 2023+; younger uninsured excluded; caps patch not cure.
Human cost documented
Rationing doses glycemic crisis; DKA hospitalization expensive ironically; employment lock job benefits; children parents childcare stress plus medical.
Black and Hispanic higher diabetes rates overlap health inequity.
Policy responses
State copay caps; Colorado etc. early;
Federal $35 Medicare; extend commercial debate;
Biosimilar competition Semglee others pressure;
PBM reform transparency legislation periodic;
Importation programs pilot Florida;
Not national price negotiation all payers — unlike VA or Europe reference pricing.
Compare globally
UK NHS pays fraction; Germany regulated; Americans cross Toronto buy — same manufacturers global market price discrimination willingness.
Pharma argument
R&D innovation cost; insulin analog improvements; risk investment — critics note profits repurchase not research; insulin discovery amortized 100 years ago moral counter.
Connection broader
Opioid same system incentives distortion;
Antibiotic underinvest opposite problem;
Veterans VA negotiates better sometimes.
Conclusion
Insulin pricing scandal because solution exists cheap production; supply chain extracts maximum until law caps or shame — Medicare cap proved political possible; extend or bust PBM model unfinished fight.
Century-old cure shouldn’t require lottery luck — yet does daily.
Chronicle is edited by Amara Okafor. Related: Healthcare Costs America · Food Insecurity America